{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:33:35Z","timestamp":1792305215387,"version":"4.4.0"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1212\/con.0000000000000768","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T10:40:11Z","timestamp":1570185611000},"page":"1236-1264","source":"Crossref","is-referenced-by-count":125,"title":["Optic Neuritis"],"prefix":"10.1212","volume":"25","author":[{"given":"Jeffrey L.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202273260901"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1144-2"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx276"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515593406"},{"issue":"12","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"109","year":"1991","unstructured":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991;109(12):1673\u20131678.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.07.020"},{"issue":"7","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archophthalmol.2012.1126","article-title":"Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica","volume":"130","author":"Merle H","year":"2012","unstructured":"Merle H Olindo S Jeannin S. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol 2012;130(7):858\u2013862. doi:10.1001\/archophthalmol.2012.1126.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","article-title":"Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group","volume":"111","author":"Keltner JL","year":"1993","unstructured":"Keltner JL Johnson CA Spurr JO Beck RW. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 1993;111(2):231\u2013234. doi:10.1001\/archopht.1993.01090020085029.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2147\/OPTH.S43894","article-title":"Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis","volume":"7","author":"Merle H","year":"2013","unstructured":"Merle H Olindo S Jeannin S. Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis. Clin Ophthalmol 2013;7:1145\u20131153. doi:10.2147\/OPTH.S43894.","journal-title":"Clin Ophthalmol"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-45"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.05.039"},{"issue":"2","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"e0172168","DOI":"10.1371\/journal.pone.0172168","article-title":"Optical coherence tomography angiography in eyes with good visual acuity recovery after treatment for optic neuritis","volume":"12","author":"Higashiyama T","year":"2017","unstructured":"Higashiyama T Nishida Y Ohji M. Optical coherence tomography angiography in eyes with good visual acuity recovery after treatment for optic neuritis. PLoS One 2017;12(2):e0172168. doi:10.1371\/journal.pone.0172168.","journal-title":"PLoS One"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312231"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf087"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.230"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.2.175"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-310206"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.7.964"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000101"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24881"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.17"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21197"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.03.038"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000231"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.11.1219"},{"issue":"6","key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jamaneurol.2018.0024","article-title":"Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: a randomized clinical trial","volume":"75","author":"Morrow SA","year":"2018","unstructured":"Morrow SA Fraser JA Day C. Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: a randomized clinical trial. JAMA Neurol 2018;75(6):690\u2013696. doi:10.1001\/jamaneurol.2018.0024.","journal-title":"JAMA Neurol"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000270"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-6957-4"},{"issue":"24","key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group","volume":"329","author":"Beck RW","year":"1993","unstructured":"Beck RW Cleary PA Trobe JD. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med 1993;329(24):1764\u20131769. doi:10.1056\/NEJM199312093292403.","journal-title":"N Engl J Med"},{"issue":"2","key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000069408","article-title":"Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosis","volume":"18","author":"Goodin DS","year":"1999","unstructured":"Goodin DS. Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosis. Neuroepidemiology 1999;18(2):53\u201363. doi:10.1159\/000069408.","journal-title":"Neuroepidemiology"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00304-4"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.7.1239"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.11.1514"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000152873.82631.B3"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8073-8"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.02.015"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316286"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-80"},{"issue":"4","key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/WNO.0000000000000166","article-title":"Should patients with bartonella neuroretinitis receive treatment?","volume":"34","author":"Bhatti MT","year":"2014","unstructured":"Bhatti MT Lee MS. Should patients with bartonella neuroretinitis receive treatment? J Neuroophthalmol 2014;34(4):412\u2013416. doi:10.1097\/WNO.0000000000000166.","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"e_1_3_1_43_2","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","author":"Optic Neuritis Study Group","year":"2008","unstructured":"Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008;65(6):727\u2013732. doi:10.1001\/archneur.65.6.727.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24351"},{"issue":"6","key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/01.wnl.0000267272.60714.42","article-title":"Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome","volume":"69","author":"Kupersmith MJ","year":"2007","unstructured":"Kupersmith MJ Gal RL Beck RW. Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome. Neurology 2007;69(6):508\u2013514. doi:10.1212\/01.wnl.0000267272.60714.42.","journal-title":"Neurology"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.05.013"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00004-1"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24554"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000345042.53843.d5"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181af78b8"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511431973"},{"issue":"2","key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica","volume":"69","author":"Kleiter I","year":"2012","unstructured":"Kleiter I Hellwig K Berthele A. Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol 2012;69(2):239\u2013245. doi:10.1001\/archneurol.2011.216.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512439439"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.4601"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000040"},{"issue":"3","key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/WNO.0000000000000593","article-title":"Optic disc edema in glial fibrillary acidic protein autoantibody-positive meningoencephalitis","volume":"38","author":"Chen JJ","year":"2018","unstructured":"Chen JJ Aksamit AJ McKeon A. Optic disc edema in glial fibrillary acidic protein autoantibody-positive meningoencephalitis. J Neuroophthalmol 2018;38(3):276\u2013281. doi:10.1097\/WNO.0000000000000593.","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(82)90184-2"},{"issue":"12","key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1136\/bjo.2009.159350","article-title":"Clinical characteristics, diagnostic criteria and therapeutic outcomes in autoimmune optic neuropathy","volume":"93","author":"Frohman L","year":"2009","unstructured":"Frohman L Dellatorre K Turbin R Bielory L. Clinical characteristics, diagnostic criteria and therapeutic outcomes in autoimmune optic neuropathy. Br J Ophthalmol 2009;93(12):1660\u20131666. doi:10.1136\/bjo.2009.159350.","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513510223"},{"issue":"2","key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"Kidd D","year":"2003","unstructured":"Kidd D Burton B Plant GT Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain 2003;126(pt 2):276\u2013284. doi:10.1093\/brain\/awg045.","journal-title":"Brain"},{"issue":"1","key":"e_1_3_1_62_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","article-title":"Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis","volume":"81","author":"Petzold A","year":"2010","unstructured":"Petzold A Pittock S Lennon V. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 2010;81(1):109\u2013111. doi:10.1136\/jnnp.2008.146894.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali C","year":"2002","unstructured":"Vitali C Bombardieri S Jonsson R. Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61(6):554\u2013558. doi:10.1016\/B978-0-12-803604-4.00004-6.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski SC","year":"2012","unstructured":"Shiboski SC Shiboski CH Criswell L. American College of Rheumatology classification criteria for Sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64(4):475\u2013487. doi:10.1002\/acr.21591.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq111"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511403958"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055843"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01193.x"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517699791"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10587"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2011.10.048"},{"issue":"1","key":"e_1_3_1_72_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/01658107.2016.1241283","article-title":"Anti-collapsing response-mediating protein-5 antibody\u2013positive paraneoplastic perioptic neuritis without typical neurological symptoms","volume":"41","author":"Igarashi N","year":"2017","unstructured":"Igarashi N Sawamura H Kaburaki T Aihara M. Anti-collapsing response-mediating protein-5 antibody\u2013positive paraneoplastic perioptic neuritis without typical neurological symptoms. Neuroophthalmology 2017;41(1):24\u201329. doi:10.1080\/01658107.2016.1241283.","journal-title":"Neuroophthalmology"},{"issue":"5","key":"e_1_3_1_73_2","first-page":"1399","article-title":"Paraneoplastic syndromes in neuro-ophthalmology","volume":"25","author":"Gordon L","year":"2019","unstructured":"Gordon L Dinkin M. Paraneoplastic syndromes in neuro-ophthalmology. Continuum (Minneap Minn) 2019;25(5, Neuro-ophthalmology):1399\u20131419.","journal-title":"Continuum (Minneap Minn)"},{"key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/EB.S29401","article-title":"Neuro-ophthalmic sarcoidosis","volume":"4","author":"Baughman RP","year":"2012","unstructured":"Baughman RP Weiss KL Golnik KC. Neuro-ophthalmic sarcoidosis. Eye Brain 2012;4:13\u201325. doi:10.2147\/EB.S29401.","journal-title":"Eye Brain"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1080\/08820530802007382"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.9.1130"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.05.020"},{"issue":"8","key":"e_1_3_1_78_2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt RY","year":"1990","unstructured":"Leavitt RY Fauci AS Bloch DA. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33(8):1101\u20131107. doi:10.1002\/art.1780330807.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"e_1_3_1_79_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5582\/irdr.2016.01014","article-title":"Granulomatosis with polyangiitis (Wegener's disease): an updated review of ocular disease manifestations","volume":"5","author":"Kubaisi B","year":"2016","unstructured":"Kubaisi B Abu Samra K Foster CS. Granulomatosis with polyangiitis (Wegener's disease): an updated review of ocular disease manifestations. Intractable Rare Dis Res 2016;5(2):61\u201369. doi:10.5582\/irdr.2016.01014.","journal-title":"Intractable Rare Dis Res"},{"issue":"1","key":"e_1_3_1_80_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10792-007-9109-y","article-title":"Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation","volume":"28","author":"Ahmed M","year":"2008","unstructured":"Ahmed M Niffenegger JH Jakobiec FA. Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol 2008;28(1):35\u201346. doi:10.1007\/s10792-007-9109-y.","journal-title":"Int Ophthalmol"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330103"},{"issue":"3","key":"e_1_3_1_82_2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.eye.6700096","article-title":"Optic neuritis as a feature of Wegener's granulomatosis","volume":"16","author":"Niskopoulou M","year":"2002","unstructured":"Niskopoulou M Du Toit N. Optic neuritis as a feature of Wegener's granulomatosis. Eye 2002;16(3):320\u2013321. doi:10.1038\/sj\/eye\/6700096.","journal-title":"Eye"},{"issue":"1","key":"e_1_3_1_83_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/01676830.2013.841716","article-title":"Wegener granulomatosis-associated optic perineuritis","volume":"33","author":"Takazawa T","year":"2014","unstructured":"Takazawa T Ikeda K Nagaoka T. Wegener granulomatosis-associated optic perineuritis. Orbit 2014;33(1):13\u201316. doi:10.3109\/01676830.2013.841716.","journal-title":"Orbit"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000527"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0b013e31820cf78a"},{"issue":"6","key":"e_1_3_1_86_2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/eye.2014.44","article-title":"Dynamics of intraretinal fluid accumulation evidenced by SD-OCT in a case of cat scratch neuroretinitis","volume":"28","author":"Finger ML","year":"2014","unstructured":"Finger ML Borruat FX. Dynamics of intraretinal fluid accumulation evidenced by SD-OCT in a case of cat scratch neuroretinitis. Eye (Lond) 2014;28(6):770\u2013771. doi:10.1038\/eye.2014.44.","journal-title":"Eye (Lond)"},{"issue":"6","key":"e_1_3_1_87_2","first-page":"1310","article-title":"Optic neuropathy secondary to cat scratch disease: distinguishing MR imaging features from other types of optic neuropathies","volume":"26","author":"Schmalfuss IM","year":"2005","unstructured":"Schmalfuss IM Dean CW Sistrom C Bhatti MT. Optic neuropathy secondary to cat scratch disease: distinguishing MR imaging features from other types of optic neuropathies. AJNR Am J Neuroradiol 2005;26(6):1310\u20131316.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"e_1_3_1_88_2","first-page":"71","article-title":"Reactive Lyme serology in optic neuritis","volume":"25","author":"Sibony P","year":"2005","unstructured":"Sibony P Halperin J Coyle PK Patel K. Reactive Lyme serology in optic neuritis. J Neuroophthalmol 2005;25(2):71\u201382. doi:10.1097\/01.WNO.0000166060.35366.70.","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e328358b1eb"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6221-8"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60103-7"},{"issue":"963","key":"e_1_3_1_92_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/pgmj.2004.020875","article-title":"Neurosyphilis with optic neuritis: an update","volume":"82","author":"Smith GT","year":"2006","unstructured":"Smith GT Goldmeier D Migdal C. Neurosyphilis with optic neuritis: an update. Postgrad Med J 2006;82(963):36\u201339. doi:10.1136\/pgmj.2004.020875.","journal-title":"Postgrad Med J"},{"issue":"9","key":"e_1_3_1_93_2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bjophthalmol-2014-306168","article-title":"Syphilitic uveitis and optic neuritis in Sydney, Australia","volume":"99","author":"Northey LC","year":"2015","unstructured":"Northey LC Skalicky SE Gurbaxani A McCluskey PJ. Syphilitic uveitis and optic neuritis in Sydney, Australia. Br J Ophthalmol 2015;99(9):1215\u20131219. doi:10.1136\/bjophthalmol-2014-306168.","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_1_94_2","first-page":"621872","article-title":"Neurosyphilis presenting as asymptomatic optic perineuritis","volume":"2012","author":"Parker SE","year":"2012","unstructured":"Parker SE Pula JH. Neurosyphilis presenting as asymptomatic optic perineuritis. Case Rep Ophthalmol Med 2012;2012:621872. doi:10.1155\/2012\/621872.","journal-title":"Case Rep Ophthalmol Med"},{"issue":"1","key":"e_1_3_1_95_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00041327-199703000-00013","article-title":"Magnetic resonance imaging of syphilitic optic neuritis\/perineuritis","volume":"17","author":"Frohman L","year":"1997","unstructured":"Frohman L Wolansky L. Magnetic resonance imaging of syphilitic optic neuritis\/perineuritis. J Neuroophthalmol 1997;17(1):57\u201359.","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-012-1017-9"},{"key":"e_1_3_1_97_2","first-page":"59","article-title":"Infectious optic neuropathies: a clinical update","volume":"7","author":"Kahloun R","year":"2015","unstructured":"Kahloun R Abroug N Ksiaa I. Infectious optic neuropathies: a clinical update. Eye Brain 2015;7:59\u201381. doi:10.2147\/EB.S69173.","journal-title":"Eye Brain"},{"issue":"4","key":"e_1_3_1_98_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12348-012-0079-5","article-title":"Clinical spectrum of tuberculous optic neuropathy","volume":"2","author":"Davis EJ","year":"2012","unstructured":"Davis EJ Rathinam SR Okada AA. Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect 2012;2(4):183\u2013189. doi:10.1007\/s12348-012-0079-5.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"9","key":"e_1_3_1_99_2","first-page":"1477","article-title":"Optic perineuritis simultaneously associated with active pulmonary tuberculosis without intraocular tuberculosis","volume":"10","author":"Ryu WY","year":"2017","unstructured":"Ryu WY Kim JS. Optic perineuritis simultaneously associated with active pulmonary tuberculosis without intraocular tuberculosis. Int J Ophthalmol 2017;10(9):1477\u20131478. doi:10.18240\/ijo.2017.09.23.","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"e_1_3_1_100_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4103\/0971-3026.57205","article-title":"Magnetic resonance imaging in central nervous system tuberculosis","volume":"19","author":"Trivedi R","year":"2009","unstructured":"Trivedi R Saksena S Gupta RK. Magnetic resonance imaging in central nervous system tuberculosis. Indian J Radiol Imaging 2009;19(4):256\u2013265. doi:10.4103\/0971-3026.57205.","journal-title":"Indian J Radiol Imaging"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00042-07"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/CON.0000000000000768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:57:37Z","timestamp":1752155857000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1212\/CON.0000000000000768"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000768","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}